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Migraine is regarded as a ‘‘neurovascular disorder’’ pre-
senting with dysfunctions of both the brain and the vascular
system. However, the initial spark causing migraine
appears to be generated within the brain, which is sup-
ported by results from recent genome-wide association
studies (GWAS) [1, 2], while vascular phenomena are
likely epiphenomena [3]. In addition, migraine with aura
has been associated with an increased risk for ischemic
stroke, while such an association is less clear for other
vascular disorders [4]. In contrast, migraine without aura,
which is far more common than migraine with aura, does
not seem to carry an increased risk for vascular disease.
So, how are the brain and the vasculature linked in
migraine? The short answer is: We do not really know. A
longer answer would ﬁrst have to state that the link is likely
complex and may include shared genetics. One approach to
decipher this link is to investigate variants in genes involved
invasculartonecontrol,includinggenescodingforthenitric
oxide synthases (NOS), a family of enzymes found in the
nervous system, cardiovascular system, and endothelium
[5]. Results at the single variant level from studies investi-
gating NOS2 and NOS3 genes [6–11] as well as the vascular
endothelial growth factor (VEGF) gene [12] in migraine did
not give a clear answer. Reasons may include the wide
phenotypic spectrum of migraine, differences in study
design, genetically heterogeneous populations, and limited
sample sizes. Analyses utilizing the integrated information
from multiple gene variants such as haplotype analyses may
be beneﬁcial as suggested by recent studies [10–12]. How-
ever, it also has to be taken into consideration that studies
using even more comprehensive and more efﬁcient
approaches like GWAS failed to identify any vascular-
related genes among migraineurs [1, 2, 13].
What we have learned from studying migraine genetics so
far?First,migraineisclinicallyandgeneticallyheterogeneous
makingitnotoriouslydifﬁculttoidentifysusceptibilitygenes.
Any susceptibility gene variant will modify the risk for
migraine to only a small to moderate degree; hence, large
studies are needed to detect them. Second, any association
found—whatever study design used—must be replicated in
independent samples/cohorts to make us conﬁdent that the
associations seen are true and not spurious. Third, novel
ways of analyses, for example, investigating the interaction
ofgenevariantsmay help to understandwhy and how certain
variants inﬂuence migraine pathophysiology. However, in
order to avoid spurious results interaction analyses should
only be performed among gene variants for which there is
strong evidence of an association with migraine and if there
is enough power to really detect potential interactions.
Conﬂict of interest Dr. Schu ¨rks has received an investigator-initi-
ated research grant from the Migraine Research Foundation. He has
received honoraria from L.E.K. Consulting for telephone surveys and
from the American Academy of Neurology for educational material.
He is a full-time employee of Bayer HealthCare Germany. None of
these disclosures represent a conﬂict of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Anttila V, Stefansson H, Kallela M, Todt U, Terwindt GM,
Calafato MS, Nyholt DR, Dimas AS, Freilinger T, Muller-
M. Schu ¨rks (&)
Department of Neurology, University Hospital Essen,
Hufelandstrasse 55, 45122 Essen, Germany
e-mail: markus.schuerks@uni-due.de
123
J Headache Pain (2012) 13:337–338
DOI 10.1007/s10194-012-0446-5Myhsok B, Artto V, Inouye M, Alakurtti K, Kaunisto MA,
Hamalainen E, de Vries B, Stam AH, Weller CM, Heinze A,
Heinze-Kuhn K, Goebel I, Borck G, Gobel H, Steinberg S, Wolf
C, Bjornsson A, Gudmundsson G, Kirchmann M, Hauge A,
Werge T, Schoenen J, Eriksson JG, Hagen K, Stovner L, Wich-
mann HE, Meitinger T, Alexander M, Moebus S, Schreiber S,
Aulchenko YS, Breteler MM, Uitterlinden AG, Hofman A, van
Duijn CM, Tikka-Kleemola P, Vepsalainen S, Lucae S, Tozzi F,
Muglia P, Barrett J, Kaprio J, Farkkila M, Peltonen L, Stefansson
K, Zwart JA, Ferrari MD, Olesen J, Daly M, Wessman M, van
den Maagdenberg AM, Dichgans M, Kubisch C, Dermitzakis ET,
Frants RR, Palotie A, International Headache Genetics C (2010)
Genome-wide association study of migraine implicates a com-
mon susceptibility variant on 8q22.1. Nat Genet 42(10):869–873
2. Chasman DI, Schu ¨rks M, Anttila V, de Vries B, Schminke U,
Launer LJ, Terwindt GM, van den Maagdenberg AM, Fendrich
K, Volzke H, Ernst F, Grifﬁths LR, Buring JE, Kallela M, Frei-
linger T, Kubisch C, Ridker PM, Palotie A, Ferrari MD, Hoff-
mann W, Zee RY, Kurth T (2011) Genome-wide association
study reveals three susceptibility loci for common migraine in the
general population. Nat Genet 43(7):695–698
3. Goadsby PJ (2009) The vascular theory of migraine: a great story
wrecked by the facts. Brain 132(Pt 1):6–7
4. Schu ¨rks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T
(2009) Migraine and cardiovascular disease: a systematic review
and meta-analysis. BMJ 339:b3914
5. Goncalves FM, Luizon MR, Speciali JG (2012) Haplotypes in
candidate genes related to nitric oxide pathway and vascular
permeability associated with migraine and aura. J Headache Pain.
doi:10.1007/s10194-012-0438-5
6. Grifﬁths LR, Nyholt DR, Curtain RP, Goadsby PJ, Brimage PJ
(1997) Migraine association and linkage studies of an endothelial
nitric oxide synthase (NOS3) gene polymorphism. Neurology
49(2):614–617
7. Borroni B, Rao R, Liberini P, Venturelli E, Cossandi M, Archetti
S, Caimi L, Padovani A (2006) Endothelial nitric oxide synthase
(Glu298Asp) polymorphism is an independent risk factor for
migraine with aura. Headache 46(10):1575–1579
8. Lea RA, Curtain RP, Shepherd AG, Brimage PJ, Grifﬁths LR
(2001) No evidence for involvement of the human inducible
nitric oxide synthase (iNOS) gene in susceptibility to typical
migraine. Am J Med Genet 105(1):110–113
9. Jia S, Ni J, Chen S, Jiang Y, Dong W, Gao Y (2011) Association
of the pentanucleotide repeat polymorphism in NOS2 promoter
region with susceptibility to migraine in a Chinese population.
DNA Cell Biol 30(2):117–122
10. Goncalves FM, Martins-Oliveira A, Speciali JG, Luizon MR,
Izidoro-Toledo TC, Silva PS, Dach F, Tanus-Santos JE (2011)
Endothelial nitric oxide synthase haplotypes associated with aura
in patients with migraine. DNA Cell Biol 30(6):363–369
11. Mansur TOS, Goncalves FM, Martins-Oliveira A, Speciali JG,
Dach F, Lacchini R, Tanus-Santos JE (2012) Inducible nitric
oxide synthase haplotype associated with migraine and aura. Mol
Cell Biochem. doi:10.1007/s11010-11012-11231-11010
12. Goncalves FM, Martins-Oliveira A, Speciali JG, Izidoro-Toledo
TC, Luizon MR, Dach F, Tanus-Santos JE (2010) Vascular
endothelial growth factor genetic polymorphisms and haplotypes
in women with migraine. DNA Cell Biol 29(7):357–362
13. Ligthart L, de Vries B, Smith AV, Ikram MA, Amin N, Hottenga
JJ, Koelewijn SC, Kattenberg VM, de Moor MH, Janssens AC,
Aulchenko YS, Oostra BA, de Geus EJ, Smit JH, Zitman FG,
Uitterlinden AG, Hofman A, Willemsen G, Nyholt DR, Mont-
gomery GW, Terwindt GM, Gudnason V, Penninx BW, Breteler
M, Ferrari MD, Launer LJ, van Duijn CM, van den Maagdenberg
AM, Boomsma DI (2011) Meta-analysis of genome-wide asso-
ciation for migraine in six population-based European cohorts.
Eur J Hum Genet 19(8):901–907
338 J Headache Pain (2012) 13:337–338
123